A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma
M. R. Valerio, P. Tagliaferri, F. Raspagliesi, F. Fulfaro, G. Badalamenti, C. Arcara, G. Cicero, A. Russo, S. Venuta, G. Guarneri, N. Gebbia
International Journal of Gynecologic Cancer Jan 2006, 16 (Suppl 1) 79-85; DOI: 10.1136/ijgc-00009577-200602001-00013
